Back to
Capstone Investment Advisors, LLC
GILD
Showing 8 of 29 quarters
Position history for
Capstone Investment Advisors, LLC's holdings in Gilead Sciences, Inc.
Yes. Capstone Investment Advisors holds 14,121 shares of GILD (Gilead Sciences), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 7,867 shares (+125.8%) from Q1 2026. Capstone Investment Advisors has held GILD since Q1 2026, across 2 quarterly 13F filings.
Current Value
$1.8M
Current Shares
14,121
Total Value Change
+$777,464
Total Shares Change
+2,115
Quarter-by-Quarter History